Nicholas Wilson, MD
Orthopaedic Surgery · O Fallon, MONPI 1902225766
Payments from drug & device makers
What this record shows
This record is dominated by education: $21,800 of the $24,524 with a category attached, or 88.9%. Smith+Nephew accounts for 87.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $11,990 and has fallen 92.9% since, to $849 in 2025.
Across 29 payments — averaging $845.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$21K
- CDC Medical LLC$2K
- Stryker$1K
- Zimmer Biomet$160
- Pacira Pharmaceuticals Incorporated$54
- Molnlycke Health Care US, LLC$20
- plus $66 from 4 others
What the payments were for
- Travel & lodging$1,2945%
- Food & beverage$1,4316%
- Education$21,80089%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 11 | $21,379 |
| CDC Medical LLC | 1 | $1,800 |
| Stryker | 8 | $1,044 |
| Zimmer Biomet | 2 | $160 |
| Pacira Pharmaceuticals Incorporated | 2 | $54 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Baudax Bio Inc. | 1 | $20 |
| Solventum Corporation | 1 | $18 |
| Exactech, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REDAPT$950
- Journey Uni$950
- VERILAST Hip$950
- Legion Revision$950
- MAKO$783
- Journey II BCS$174
- TRIATHLON$157
- ACCOLADE$157
- INSIGNIA$157
- TRITANIUM$145
- REAL INTELLIGENCE$132
How this compares
$24,524 in reported general payments places this provider in the 80th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 769 | $7,395 |
| Celecoxib | 207 | $4,342 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 187 | $1,441 |
| Tramadol Hcl | 178 | $483 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 63 | $460 |
| Methylprednisolone | 43 | $287 |
| Cephalexin | 26 | $149 |
| Oxycodone Hcl | 29 | $133 |
| Amoxicillin | 95 | $123 |
| Clindamycin Hcl | 34 | $69 |
| Meloxicam | 28 | $63 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in O Fallon
- Matthew SmithColumbia$2.9M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Peter ChalmersSaint Louis$603K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
- Lionel MetzSaint Louis$428K
- Michael HellmanLees Summit$365K
- Jon CarlsonSaint Louis$354K
- Akin CilKansas City$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.